Yoon AR - Search Results

1

Increased incidence of gastric cancer in renal transplant recipients.

Park JM, Choi MG, Yang CW, Jung CK, Lee SK, Yoon AR, Kim YS, Chung IS. Park JM, et al. Among authors: yoon ar. J Clin Gastroenterol. 2012 Nov-Dec;46(10):e87-91. doi: 10.1097/MCG.0b013e31825c0b3a. J Clin Gastroenterol. 2012. PMID: 22810108

2

Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1.

Kim DN, Seo MK, Choi H, Kim SY, Shin HJ, Yoon AR, Tao Q, Rha SY, Lee SK. Kim DN, et al. Among authors: yoon ar. J Gen Virol. 2013 Mar;94(Pt 3):497-506. doi: 10.1099/vir.0.045237-0. Epub 2012 Nov 21. J Gen Virol. 2013. PMID: 23175241

3

Epidemiology of eating disordered symptoms in the Korean general population using a Korean version of the Eating Attitudes Test.

Lee YH, Rhee MK, Park SH, Sohn CH, Chung YC, Hong SK, Lee BK, Chang P, Yoon AR. Lee YH, et al. Among authors: yoon ar. Eat Weight Disord. 1998 Dec;3(4):153-61. doi: 10.1007/BF03340004. Eat Weight Disord. 1998. PMID: 10728165

4

Clinical and Genetic Characteristics of Korean Patients Diagnosed with Chronic Enteropathy Associated with SLCO2A1 Gene: A KASID Multicenter Study.

Hong HS, Baek J, Park JC, Lee HS, Park D, Yoon AR, Park SJ, Hong SN, Koh SJ, Lee CK, Lee BI, Hwang SW, Park SH, Myung SJ, Yang SK, Song K, Ye BD; IBD Research Group of the Korean Association for the Study of Intestinal Diseases. Hong HS, et al. Among authors: yoon ar. Gut Liver. 2022 Nov 15;16(6):942-951. doi: 10.5009/gnl210415. Epub 2022 May 25. Gut Liver. 2022. PMID: 35611666 Free PMC article.

5

Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression.

Lee YH, Yoon AR, Yun CO, Chung KC. Lee YH, et al. Among authors: yoon ar. J Biol Chem. 2024 Apr;300(4):107206. doi: 10.1016/j.jbc.2024.107206. Epub 2024 Mar 20. J Biol Chem. 2024. PMID: 38519031 Free PMC article.

6

Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?

Yoon AR, Hong J, Jung BK, Ahn HM, Zhang S, Yun CO. Yoon AR, et al. Cancer Lett. 2023 Nov 28;579:216456. doi: 10.1016/j.canlet.2023.216456. Epub 2023 Nov 7. Cancer Lett. 2023. PMID: 37940067 Free article. Review.

7

Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements.

Yun CO, Hong J, Yoon AR. Yun CO, et al. Among authors: yoon ar. Front Immunol. 2022 Aug 25;13:953410. doi: 10.3389/fimmu.2022.953410. eCollection 2022. Front Immunol. 2022. PMID: 36091031 Free PMC article. Review.

8

Why is Mortalin a Potential Therapeutic Target for Cancer?

Yoon AR, Wadhwa R, Kaul SC, Yun CO. Yoon AR, et al. Front Cell Dev Biol. 2022 Jun 29;10:914540. doi: 10.3389/fcell.2022.914540. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35859897 Free PMC article. Review.

9

ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells.

Jung BK, Kim YJ, Hong J, Chang HG, Yoon AR, Yun CO. Jung BK, et al. Among authors: yoon ar. Int J Mol Sci. 2022 Jun 27;23(13):7127. doi: 10.3390/ijms23137127. Int J Mol Sci. 2022. PMID: 35806132 Free PMC article.

10

Bioreducible polymer-mediated delivery of oncolytic adenovirus can attenuate antiviral immune response and concurrently enhance the induction of antitumor immune response to effectively prevent metastasis.

Kasala D, Lee SH, Hong J, Oh E, Yoon AR, Yun CO. Kasala D, et al. Among authors: yoon ar. Biomater Sci. 2022 Jul 26;10(15):4293-4308. doi: 10.1039/d2bm00200k. Biomater Sci. 2022. PMID: 35766864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page